Virus News and Research

Latest Virus News and Research

Computer simulation forecasts favorable trends in eradicating hepatitis C

5 Aug 2014

Hepatitis C could become a rare disease by 2036

Effective new drugs and screening would make hepatitis C a rare disease by 2036, according to a computer simulation conducted by The University of Texas MD Anderson Cancer Center and the University of Pittsburgh Graduate School of Public Health. The results of the simulation are reported in the August 5 edition of the journal Annals of Internal Medicine.

5 Aug 2014

New technique for studying lifecycle of hepatitis B virus can help develop cure for disease

A new technique for studying the lifecycle of the hepatitis B virus could help researchers develop a cure for the disease.

5 Aug 2014

Herpes zoster vaccine effective in protecting older adults against shingles, even after chemotherapy

The herpes zoster vaccine continues to be effective in protecting older adults against shingles, even after they undergo chemotherapy, according to a Kaiser Permanente study published today in the journal Clinical Infectious Diseases.

5 Aug 2014

Biomarker for head and neck cancers identified

Although mutations in a gene dubbed "the guardian of the genome" are widely recognized as being associated with more aggressive forms of cancer, researchers at the University of California, San Diego School of Medicine have found evidence suggesting that the deleterious health effects of the mutated gene may in large part be due to other genetic abnormalities, at least in squamous cell head and neck cancers.

4 Aug 2014

Research roundup: The effect of expensive cancer therapies; missed hospital handovers; children's mental health needs

Medicare uses more than a dozen different payment systems to set payment rates for the medical items and services the program covers for beneficiaries.

4 Aug 2014

Study shows sustained immunogenicity, efficacy and safety of GlaxoSmithKline's HPV vaccine

A long-term follow-up study (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity and safety of GlaxoSmithKline's human papilloma virus (HPV) vaccine Cervarix.

1 Aug 2014

Researchers one step closer to finding treatment for dengue fever

There have been several news reports that the world's first dengue vaccine will be available next year. However, the latest clinical trials show that the vaccine only provides a protection of around 50 per cent for DENV-2 and DENV-1, which are commonly found in Singapore.

1 Aug 2014

Rice, Baylor scientists analyze how influenza-related proteins help infect cells

A flu virus acts like a Trojan horse as it attacks and infects host cells. Scientists at Rice University and Baylor College of Medicine have acquired a clearer view of the well-hidden mechanism involved.

1 Aug 2014

Washington bioengineers discover potential method to protect women from contracting HIV

Soon, protection from HIV infection could be as simple as inserting a medicated, disappearing fabric minutes before having sex.

31 Jul 2014

Virologists find cells are having to fight virus constantly, even in dormant phase

Scientists investigating the herpes virus have been surprised to find an ongoing conflict in the cells of sufferers, even when the virus is apparently dormant.

30 Jul 2014

Conjoint Analysis method can show how important different treatment goals are for respondents

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues still need to be clarified.

30 Jul 2014

Viewpoints: Medicare's future finances; 'promising deal' on VA; Texas 'war on abortion'

Medicare got some good news Monday, when the trustees who oversee its finances announced that the fund that pays for hospital care will remain solvent until 2030, four years longer than its forecast from last year.

30 Jul 2014

State highlights: Va. Lt. Gov.'s politics and pediatrics juggle; Md. hospital error reporting; ruling on Fla. 'Docs V. Glocks' law

A selection of health policy news from Virginia, Maryland, Florida, New York, Wisconsin, Washington state, New Jersey and Kansas.

29 Jul 2014

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according to the results of two studies published in The Lancet.

29 Jul 2014

Researchers confirm for the first time that achalasia is autoimmune in origin

Achalasia is a rare disease - it affects 1 in 100,000 people - characterized by a loss of nerve cells in the esophageal wall.

29 Jul 2014

First systematic analysis indicates that about 1 in 3000 donors in England have HEV

The first systematic analysis of hepatitis E virus (HEV) transmission by blood components indicates that about 1 in 3000 donors in England have HEV in their plasma. The findings, published in The Lancet, suggest that around 1200 HEV-containing blood components (eg, red cells, platelets, and fresh frozen plasma) are likely to be transfused every year in England.

29 Jul 2014

Virus News and Research

Latest Virus News and Research

Computer simulation forecasts favorable trends in eradicating hepatitis C

Hepatitis C could become a rare disease by 2036

New technique for studying lifecycle of hepatitis B virus can help develop cure for disease

Herpes zoster vaccine effective in protecting older adults against shingles, even after chemotherapy

Biomarker for head and neck cancers identified

Research roundup: The effect of expensive cancer therapies; missed hospital handovers; children's mental health needs

Study shows sustained immunogenicity, efficacy and safety of GlaxoSmithKline's HPV vaccine

Researchers one step closer to finding treatment for dengue fever

Rice, Baylor scientists analyze how influenza-related proteins help infect cells

Washington bioengineers discover potential method to protect women from contracting HIV

Virologists find cells are having to fight virus constantly, even in dormant phase

Conjoint Analysis method can show how important different treatment goals are for respondents

Viewpoints: Medicare's future finances; 'promising deal' on VA; Texas 'war on abortion'

State highlights: Va. Lt. Gov.'s politics and pediatrics juggle; Md. hospital error reporting; ruling on Fla. 'Docs V. Glocks' law

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

Researchers confirm for the first time that achalasia is autoimmune in origin

First systematic analysis indicates that about 1 in 3000 donors in England have HEV

Researchers identify porcine enterovirus G using next-generation sequencing

Little-known supportive cells in brain may play major role in cognitive function

Doctors remind parents about importance of immunizing children

A new way of characterising biomolecules eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in